FindTrial
Sign In

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for the treatment of trauma patients in distress from torso hemorrhage; a prospective follow-up study in a Dutch level I trauma center

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for the treatment of trauma patients in distress from torso hemorrhage; a prospective follow-up study in a Dutch level I trauma center

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25387
Enrollment
30
Registered
2020-07-13
Start date
2020-07-08
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma patients who are treated using REBOA for presumed traumatic life-threatening hemorrhage or traumatic cardiac arrest.

Interventions

None listed

Sponsors

Erasmus MC, University Medical Center Rotterdam, Trauma Research Unit Department of Surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presented to Erasmus MC because of a physical trauma 2. Treatment attempted using REBOA (whether or not successful) for presumed traumatic life-threatening hemorrhage or traumatic cardiac arrest. 3. Provision of deferred informed consent (IC) by patient or proxy

Exclusion criteria

Exclusion criteria: No exclusion criteria apply.

Design outcomes

Primary

MeasureTime frame
Whether REBOA was successful—

Secondary

MeasureTime frame
The time needed to obtain hemorrhage control with REBOA; Complications related to REBOA; General complications; Survival; REBOA procedure data; Patient demographics; Injury characteristics; Clinical parameters; Deployed resources and interventions; Hospital course.—

Contacts

Public ContactR. Hoencamp

Erasmus MC, University Medical Center Rotterdam

r.hoencamp@erasmusmc.nl+31107031050

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)